Cancer Research UK Cambridge Institute

Our Institute combines basic and clinical research with innovative technologies to address critical questions in the prevention, diagnosis and treatment of cancer. We are a department of the University of Cambridge, core funded by Cancer Research UK.

About us

Latest news

  • News

    Technique for tracking resistant cancer cells could lead to new treatments for relapsing breast cancer patients

    Scientists from the IMAXT team have managed to identify and kill those breast cancer cells that evade standard treatments in a study in mice. The approach is a step towards the development of new treatments to prevent relapse in patients. Tumours are complex entities made up of many types of cells, including cancer cells and […]

    Find out more
  • News

    Institute scientists and startups shortlisted for the Innovation & Entrepreneurship Awards

    Institute researchers and spin-out companies have been shortlisted for the Cancer Research Horizons Innovation & Entrepreneurship Awards. The Awards recognise the UK’s most innovative efforts to translate research discoveries into benefits for cancer patients. Early-career Entrepreneur of the Year Award Dr Dario Bressan, Dr Stephanie Mack, and Dr Mireia Crispin have all been shortlisted for […]

    Find out more
  • News

    Raza Ali awarded €1.5 million European Research Council Starting Grant

    Dr Raza Ali has been awarded a €1.5 million European Research Council (ERC) Starting Grant for his research on immunotherapy and the tumour microenvironment in breast cancer. Immunotherapy has transformed the treatment of certain cancers, such as melanoma and non-small cell lung cancer, but its role in the treatment of breast cancer is still unclear. […]

    Find out more
  • News

    Lina Hacker awarded Postgraduate Student Thesis Prize

    Lina Hacker has been announced as the winner of this year’s Postgraduate Student Thesis Prize. The Prize is awarded each year to an exceptional postgraduate student who has completed an outstanding piece of work during their studies. Lina Hacker completed her PhD in the Bohndiek Group, supervised by Professor Sarah Bohndiek. For her studies, Hacker […]

    Find out more

Other Cancer Research UK funded Institutes